{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:12:14Z","timestamp":1791335534966,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T00:00:00Z","timestamp":1374192000000},"content-version":"vor","delay-in-days":4551,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA77415"],"award-info":[{"award-number":["CA77415"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA27632"],"award-info":[{"award-number":["R01 CA27632"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["BMH4-CT96-1133"],"award-info":[{"award-number":["BMH4-CT96-1133"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","award":["DAMD17-94-J-4260"],"award-info":[{"award-number":["DAMD17-94-J-4260"]}],"id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1086\/318181","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T15:01:40Z","timestamp":1027695700000},"page":"410-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":408,"title":["Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers"],"prefix":"10.1016","volume":"68","author":[{"given":"Deborah","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1086\/318181_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/jmbi.1999.2904","article-title":"The N-terminal domain of the human Rad51 binding surface as revealed by NMR","volume":"290","author":"Aihara","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1086\/318181_bib2","first-page":"5485","article-title":"Nuclear location and cell cycle regulation of the BRCA2 protein","volume":"57","author":"Bertwistle","year":"1997","journal-title":"Cancer Res"},{"key":"10.1086\/318181_bib3","first-page":"2546","article-title":"Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumour breast tissue compared with normal tissue","volume":"59","author":"Bi\u00e8che","year":"1999","journal-title":"Cancer Res"},{"key":"10.1086\/318181_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ng0596-22","article-title":"Internal repeats in the BRCA2 protein sequence","volume":"13","author":"Bork","year":"1996","journal-title":"Nat Genet"},{"key":"10.1086\/318181_bib5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","author":"Breast Cancer Linkage Consortium","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1086\/318181_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ng1297-423","article-title":"Tumorigenesis and a DNA repair defect in mice with a truncating BRCA2 mutation","volume":"17","author":"Connor","year":"1997","journal-title":"Nat Genet"},{"key":"10.1086\/318181_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","article-title":"BRCA2 germline mutations in male breast cancer cases and breast cancer families","volume":"13","author":"Couch","year":"1996","journal-title":"Nat Genet"},{"key":"10.1086\/318181_bib8","first-page":"995","article-title":"High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history","volume":"59","author":"Csokay","year":"1999","journal-title":"Cancer Res"},{"key":"10.1086\/318181_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13","volume":"61","author":"Easton","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1086\/318181_bib10","first-page":"1457","article-title":"Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence","volume":"57","author":"Ford","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1086\/318181_bib11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1086\/318181_bib12","first-page":"313","article-title":"Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population","volume":"60","author":"Friedman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1086\/318181_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation in risks of breast an ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat Genet"},{"key":"10.1086\/318181_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/1998\/613765","article-title":"Clues to the function of the tumour susceptibility gene BRCA2","volume":"14","author":"Gayther","year":"1998","journal-title":"Dis Markers"},{"key":"10.1086\/318181_bib15","first-page":"1367","article-title":"BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease","volume":"58","author":"Haraldsson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1086\/318181_bib16","first-page":"3663","article-title":"High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients","volume":"56","author":"Johannesdottir","year":"1996","journal-title":"Cancer Res"},{"key":"10.1086\/318181_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/gepi.1370050611","article-title":"Programs for pedigree analysis: MENDEL, FISHER and dGENE","volume":"5","author":"Lange","year":"1988","journal-title":"Genet Epidemiol"},{"key":"10.1086\/318181_bib18","first-page":"4578","article-title":"Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells","volume":"56","author":"Lu","year":"1996","journal-title":"Cancer Res"},{"key":"10.1086\/318181_bib19","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/bjc.1997.574","article-title":"Germline BRCA2 mutations in men with breast cancer","volume":"76","author":"Mavraki","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1086\/318181_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1086\/302853","article-title":"BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer","volume":"66","author":"Moslehi","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1086\/318181_bib21","series-title":"Vol 5, IARC sci publ 88, in: Cancer Incidence in Five Continents","year":"1987"},{"key":"10.1086\/318181_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng1096-188","article-title":"The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%","volume":"14","author":"Oddoux","year":"1996","journal-title":"Nat Genet"},{"key":"10.1086\/318181_bib23","series-title":"Vol 6, IARC sci publ 120, in: Cancer incidence in five continents","year":"1992"},{"key":"10.1086\/318181_bib24","series-title":"Vol 7, IARC sci publ 143, in: Cancer incidence in five continents","year":"1997"},{"key":"10.1086\/318181_bib25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/386804a0","article-title":"Embryonic lethality and radiation hypersensitivity mediated by RAD51in mice lacking BRCA2","volume":"386","author":"Sharan","year":"1997","journal-title":"Nature"},{"key":"10.1086\/318181_bib26","doi-asserted-by":"crossref","first-page":"13920","DOI":"10.1073\/pnas.96.24.13920","article-title":"Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations","volume":"96","author":"Spain","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1086\/318181_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","article-title":"The complete BRCA2 gene in chromosome 13q-linked kindreds","volume":"12","author":"Tavtigian","year":"1996","journal-title":"Nat Genet"},{"key":"10.1086\/318181_bib28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/MCB.17.1.444","article-title":"Localization of BRCA1 and a splice site variant identifies the nuclear localization signal","volume":"17","author":"Thakur","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1086\/318181_bib29","first-page":"1079","article-title":"Study of a single BRCA2 mutation with high carrier frequency in a small population","volume":"60","author":"Thorlacius","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1086\/318181_bib30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(98)03300-5","article-title":"Population-based study of risk of breast cancer in carriers of BRCA2 mutation","volume":"352","author":"Thorlacius","year":"1998","journal-title":"Lancet"},{"key":"10.1086\/318181_bib31","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/jmg.32.12.982","article-title":"A large multisite cancer familiy is linked to BRCA2","volume":"32","author":"Tonin","year":"1995","journal-title":"J Med Genet"},{"key":"10.1086\/318181_bib32","first-page":"41","article-title":"Multiplying functions for BRCA1 and BRCA2? meeting report, The Breakthrough Breast Cancer Second International Workshop on the Function of BRCA1 and BRCA2, Cambridge, UK, 9-10 September 1999","volume":"1470","author":"Venkitaraman","year":"2000","journal-title":"Biochem Biophys Acta"},{"key":"10.1086\/318181_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer","volume":"91","author":"Warner","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1086\/318181_bib34","series-title":"Vol 3, IARC sci publ 15, in: Cancer incidence in five continents","year":"1976"},{"key":"10.1086\/318181_bib35","series-title":"Vol 4, IARC sci publ 42, in: Cancer incidence in five continents","year":"1982"},{"key":"10.1086\/318181_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.onc.1200924","article-title":"Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b","volume":"14","author":"Wilson","year":"1997","journal-title":"Oncogene"},{"key":"10.1086\/318181_bib37","doi-asserted-by":"crossref","first-page":"31941","DOI":"10.1074\/jbc.272.51.31941","article-title":"RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRCA2","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1086\/318181_bib39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1086\/318181_bib38","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929707640932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929707640932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:14:43Z","timestamp":1762078483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929707640932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["S0002929707640932"],"URL":"https:\/\/doi.org\/10.1086\/318181","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1086\/318181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}